REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pathwork Diagnostics, Inc., a privately held molecular diagnostics company focused on oncology, announced that results demonstrating the capability of its Tissue of Origin Test to be performed on a variety of FFPE fluid specimens will be presented this week at the 100th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP) in San Antonio, TX.
